1146972-37-3

Basic information

• Product Name: N'-[3-(4-chloro-3-methylindole-1-sulfonyl)phenyl]-N,N-dimethylethane-1,2-diamine
• CAS NO: 1146972-37-3
• Molecular Weight: 391.922
• Mol File: 1146972-37-3.mol

Chemical Properties

• CAS DataBase Reference: N'-[3-(4-chloro-3-methylindole-1-sulfonyl)phenyl]-N,N-dimethylethane-1,2-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: N'-[3-(4-chloro-3-methylindole-1-sulfonyl)phenyl]-N,N-dimethylethane-1,2-diamine(1146972-37-3)
• EPA Substance Registry System: N'-[3-(4-chloro-3-methylindole-1-sulfonyl)phenyl]-N,N-dimethylethane-1,2-diamine(1146972-37-3)

Safety Data

• Hazardous Substances Data: 1146972-37-3(Hazardous Substances Data)

Upstream product

• 4584-46-7 (2-chloroethyl)dimethylamine hydrochloride 
• 858236-14-3 4-chloro-3-methyl-1H-indole 
• 121-51-7 3-nitrobenzenesulphonyl chloride 

Relevant articles and documents

Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists

A series of N′-[3-(indole-1-sulfonyl) aryl]-N,N-dimethyl ethane-1,2-diamines and N′-[3-(indole-1-sulfonyl) aryl]-N,N-dimethyl propane-1,3-diamines was designed and synthesized as 5-HT6 receptor ligands. These compounds, when screened in a functional reporter gene-based assay, displayed potent antagonistic activity with Kb values in the range of 1.8-60 nM. The lead compound 9y has shown good ADME surrogate properties, acceptable pharmacokinetic profile and is active in animal models of cognition like novel object recognition test and Morris water maze. It was selected for detailed profiling.

AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS

The present invention relates to novel amino arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them: The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The compounds of the invention are useful in the treatment of various disorders that are related to 5-HT6 receptor functions. Specifically, the compounds of this invention are also useful in the treatment of various CNS disorders, hematological disorders, eating disorders, obesity, anxiety, depression, diseases associated with pain, respiratory diseases, gastrointestinal, cardiovascular diseases and cancer

AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS FIELD OF INVENTION

The present invention relates to novel amino arylsulfonamide compounds of the formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them: The present invention